Ord's frontier-cost argument is right as far as it goes, but the piece doesn't engage with the counter-trend: inference cost for a fixed capability level has been falling faster than Moore's law. Pushing the frontier will likely keep getting more expensive and concentrated among a few players, while the intelligence needed for more mundane tasks keeps getting cheaper.

That raises a question: if practical-tier inference commoditizes, how does any company justify the ever-larger capex to push the frontier?

OpenAI's pitch is that their business model should "scale with the value intelligence delivers." Concretely, that means moving beyond API fees into licensing and outcome-based pricing in high-value R&D sectors like drug discovery and materials science, where a single breakthrough dwarfs compute cost. That's one possible answer, though it's unclear whether the mechanism will work in practice.